202 related articles for article (PubMed ID: 2179137)
1. Infectious complications after 809 biliary tract operations and results of a prospective randomized single-blind study comparing cefoxitin versus ampicillin plus an inhibitor of beta-lactamases.
Wittmann DH; Koltowski P; Oleszkiewicz J; Walker AP
Infection; 1990; 18(1):41-7. PubMed ID: 2179137
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic prophylaxis in transurethral surgery: a comparison of sulbactam-ampicillin and cefoxitin.
Dørflinger T; Madsen PO
Infection; 1985; 13(2):66-9. PubMed ID: 2987133
[TBL] [Abstract][Full Text] [Related]
3. Ampicillin-sulbactam versus cefoxitin for prophylaxis in high-risk patients undergoing abdominal surgery.
Paladino JA; Rainstein MA; Serrianne DJ; Przylucki JE; Welage LS; Collura ML; Schentag JJ
Pharmacotherapy; 1994; 14(6):734-9. PubMed ID: 7885978
[TBL] [Abstract][Full Text] [Related]
4. Single-agent therapy for acute pelvic inflammatory disease: sulbactam/ampicillin versus cefoxitin.
Hemsell DL; Bawdon RE; Hemsell PG; Nobles BJ; Heard MC
J Int Med Res; 1990; 18 Suppl 4():85D-89D. PubMed ID: 2282973
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections.
Walker AP; Nichols RL; Wilson RF; Bivens BA; Trunkey DD; Edmiston CE; Smith JW; Condon RE
Ann Surg; 1993 Feb; 217(2):115-21. PubMed ID: 8439209
[TBL] [Abstract][Full Text] [Related]
6. Sulbactam/ampicillin compared with cefoxitin for chemoprophylaxis in elective colorectal surgery.
de la Hunt MN; Karran SJ
Dis Colon Rectum; 1986 Mar; 29(3):157-9. PubMed ID: 3002735
[TBL] [Abstract][Full Text] [Related]
7. Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections.
Messick CR; Mamdani M; McNicholl IR; Danziger LH; Rodvold KA; Condon RE; Walker AP; Edmiston CE
Pharmacotherapy; 1998; 18(1):175-83. PubMed ID: 9469691
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind comparison of ampicillin/sulbactam and ceftriaxone in the prevention of surgical-site infections after neurosurgery.
Zhu XL; Wong WK; Yeung WM; Mo P; Tsang CS; Pang KH; Po YC; Aung TH
Clin Ther; 2001 Aug; 23(8):1281-91. PubMed ID: 11558864
[TBL] [Abstract][Full Text] [Related]
9. A comparison of ampicillin/sulbactam and cefoxitin in the treatment of bacterial skin and skin-structure infections.
Weigelt JA
Adv Ther; 1994; 11(4):183-91. PubMed ID: 10150262
[TBL] [Abstract][Full Text] [Related]
10. Abdominal surgical wound infection is lowered with improved perioperative enterococcus and bacteroides therapy.
Weigelt JA; Easley SM; Thal ER; Palmer LD; Newman VS
J Trauma; 1993 Apr; 34(4):579-84; discussion 584-5. PubMed ID: 8487344
[TBL] [Abstract][Full Text] [Related]
11. Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease.
Hemsell DL; Heard MC; Hemsell PG; Nobles BJ
Drugs; 1988; 35 Suppl 7():39-42. PubMed ID: 3220008
[TBL] [Abstract][Full Text] [Related]
12. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology.
Chan JC
Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324
[TBL] [Abstract][Full Text] [Related]
13. Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections.
Senft HH; Stiglmayer R; Eibach HW; Koerner H
Drugs; 1986; 31 Suppl 2():18-21. PubMed ID: 3013568
[TBL] [Abstract][Full Text] [Related]
14. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.
Talan DA; Summanen PH; Finegold SM
Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706
[TBL] [Abstract][Full Text] [Related]
15. Perioperative prophylaxis with sulbactam and ampicillin compared with metronidazole and cefotaxime in the prevention of wound infection in children undergoing appendectomy.
Foster MC; Morris DL; Legan C; Kapila L; Slack RC
J Pediatr Surg; 1987 Sep; 22(9):869-72. PubMed ID: 3499502
[TBL] [Abstract][Full Text] [Related]
16. Perioperative systemic antibiotics for prophylaxis of infections in breast surgery: sulbactam/ampicillin versus mezlocillin/oxacillin.
Engel K; Wildfeuer A
Suppl Int J Gynecol Obstet; 1989; 2():29-34. PubMed ID: 2679681
[TBL] [Abstract][Full Text] [Related]
17. The value of chemoprophylaxis against Enterococcus species in elective cholecystectomy: a randomized study of cefuroxime vs ampicillin-sulbactam.
Dervisoglou A; Tsiodras S; Kanellakopoulou K; Pinis S; Galanakis N; Pierakakis S; Giannakakis P; Liveranou S; Ntasiou P; Karampali E; Iordanou C; Giamarellou H
Arch Surg; 2006 Dec; 141(12):1162-7. PubMed ID: 17178957
[TBL] [Abstract][Full Text] [Related]
18. Perioperative antibiotic use in high-risk penetrating hollow viscus injury: a prospective randomized, double-blind, placebo-control trial of 24 hours versus 5 days.
Kirton OC; O'Neill PA; Kestner M; Tortella BJ
J Trauma; 2000 Nov; 49(5):822-32. PubMed ID: 11086771
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis.
McGregor JA; Crombleholme WR; Newton E; Sweet RL; Tuomala R; Gibbs RS
Obstet Gynecol; 1994 Jun; 83(6):998-1004. PubMed ID: 8190448
[TBL] [Abstract][Full Text] [Related]
20. A bacteriological assessment of ampicillin with sulbactam as antibiotic prophylaxis in patients undergoing biliary tract operations. The West of Scotland Surgical Infection Study Group.
Edwards GF; Lindsay G; Taylor EW
J Hosp Infect; 1990 Oct; 16(3):249-55. PubMed ID: 1979575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
